Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
| Autor: | Wenxia Wang, Swarna Bale, Jun Wei, Bharath Yalavarthi, Dibyendu Bhattacharyya, Jing Jing Yan, Hiam Abdala-Valencia, Dan Xu, Hanshi Sun, Roberta G. Marangoni, Erica Herzog, Sergejs Berdnikovs, Stephen D. Miller, Amr H. Sawalha, Pei-Suen Tsou, Kentaro Awaji, Takashi Yamashita, Shinichi Sato, Yoshihide Asano, Chinnaswamy Tiruppathi, Anjana Yeldandi, Bettina C. Schock, Swati Bhattacharyya, John Varga |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Mice
Knockout Scleroderma Systemic Multidisciplinary General Physics and Astronomy General Chemistry Fibroblasts Fibrosis General Biochemistry Genetics and Molecular Biology Fibroblasts - metabolism Disease Models Animal Bleomycin Mice Scleroderma Systemic - metabolism Transforming Growth Factor beta Transforming Growth Factor beta - metabolism Animals Receptors Adiponectin - metabolism Ubiquitins - metabolism Receptors Adiponectin Ubiquitins Cells Cultured Signal Transduction Skin Skin - pathology Signal Transduction - genetics |
| Zdroj: | Wang, W, Bale, S, Wei, J, Yalavarthi, B, Bhattacharyya, D, Yan, J J, Abdala-Valencia, H, Xu, D, Sun, H, Marangoni, R G, Herzog, E, Berdnikovs, S, Miller, S D, Sawalha, A H, Tsou, P-S, Awaji, K, Yamashita, T, Sato, S, Asano, Y, Tiruppathi, C, Yeldandi, A, Schock, B C, Bhattacharyya, S & Varga, J 2022, ' Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs ', Nature Communications, vol. 13, 6358 . https://doi.org/10.1038/s41467-022-33767-y |
| DOI: | 10.1038/s41467-022-33767-y |
| Popis: | In addition to autoimmune and inflammatory diseases, variants of the TNFAIP3 gene encoding the ubiquitin-editing enzyme A20 are also associated with fibrosis in systemic sclerosis (SSc). However, it remains unclear how genetic factors contribute to SSc pathogenesis, and which cell types drive the disease due to SSc-specific genetic alterations. We therefore characterize the expression, function, and role of A20, and its negative transcriptional regulator DREAM, in patients with SSc and disease models. Levels of A20 are significantly reduced in SSc skin and lungs, while DREAM is elevated. In isolated fibroblasts, A20 mitigates ex vivo profibrotic responses. Mice haploinsufficient for A20, or harboring fibroblasts-specific A20 deletion, recapitulate major pathological features of SSc, whereas DREAM-null mice with elevated A20 expression are protected. In DREAM-null fibroblasts, TGF-β induces the expression of A20, compared to wild-type fibroblasts. An anti-fibrotic small molecule targeting cellular adiponectin receptors stimulates A20 expression in vitro in wild-type but not A20-deficient fibroblasts and in bleomycin-treated mice. Thus, A20 has a novel cell-intrinsic function in restraining fibroblast activation, and together with DREAM, constitutes a critical regulatory network governing the fibrotic process in SSc. A20 and DREAM represent novel druggable targets for fibrosis therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|